Disease burden of asbestos-related diseases in China (1990–2023) based on GBD estimates: A call for stronger labor protection laws
PLOS One · 18.05.2026 · 21 (5) · e0349392
DOI: 10.1371/journal.pone.0349392 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.05.2026. Verfasst von Duo An und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Law, Xi'an Jiaotong University, Xi'an, Shaanxi Province, the People's Republic of China. Hauptthemen laut MEDLINE: Asbestos, Asbestosis, Occupational Exposure. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Asbestos exposure remains a persistent occupational hazard in China, yet updated national estimates of asbestos-related diseases (ARDs) after 2019 are scarce. This study quantified long-term trends and demographic patterns of ARDs from 1990 to 2023 using Global Burden of Disease data and joinpoint regression.
Methods
We analyzed incidence, prevalence, deaths, and disability-adjusted life years (DALYs) for asbestosis and asbestos-attributable cancers (mesothelioma, tracheal/bronchus/lung cancer, laryngeal cancer, and ovarian cancer). Absolute numbers and age-standardized rates were assessed overall and stratified by sex and age. joinpoint regression identified significant temporal inflection points.
Results
The absolute burden of ARDs increased continuously from 1990 to 2023. Age-standardized prevalence and incidence rates of asbestosis peaked in 2001, while mortality and DALY rates peaked in 2004. Major turning points for asbestos-attributable cancers occurred around 2010–2011, marking historical peaks followed by declines. A modeled increase in mortality and DALYs was observed from 2020 to 2022 across nearly all ARDs. Males consistently demonstrated higher burdens than females, and older adults (≥65 years) carried the greatest burden, with a secondary mesothelioma peak at 55–59 years in males.
Conclusions
Although ARD indicators have declined from historical peaks, a statistically modeled increase was observed in 2020–2022, warranting continued public-health attention. These findings aim to provide evidence for clinicians, epidemiologists, and policymakers to strengthen occupational disease prevention, reinforce labor protection laws, and improve asbestos-control policies in China.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Law, Xi'an Jiaotong University, Xi'an, Shaanxi Province, the People's Republic of China.
- Law School, XinJiang University, Urumqi City, Xinjiang Province, the People's Republic of China.
- School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi Province, the People's Republic of China.
- Department of Rheumatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, the People's Republic of China.
ORCID-Profile: Chenxiao Zhang, Hanchao Li
Zitieren
APA
An, D., Shi, Z., Zhang, C., Song, S., Wang, L., & Li, H. (2026). Disease burden of asbestos-related diseases in China (1990–2023) based on GBD estimates: A call for stronger labor protection laws. PLOS One, 21(5), e0349392. https://doi.org/10.1371/journal.pone.0349392
Vancouver
An D, Shi Z, Zhang C, Song S, Wang L, Li H. Disease burden of asbestos-related diseases in China (1990–2023) based on GBD estimates: A call for stronger labor protection laws. PLOS One. 2026;21(5):e0349392. doi:10.1371/journal.pone.0349392
BibTeX
@article{An2026,
author = {An, Duo and Shi, Zherui and Zhang, Chenxiao and Song, Shichang and Wang, Lu and Li, Hanchao},
title = {Disease burden of asbestos-related diseases in China (1990–2023) based on GBD estimates: A call for stronger labor protection laws},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0349392},
doi = {10.1371/journal.pone.0349392}
}
EUVIMED